Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11248-11254
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11248
Table 1 Posttreatment thrombolysis in myocardial infarction flow grade of diseased vessels, n (%)
Group
n
TIMI
Grades 0 to II
Grade III
Experimental36028 (7.8)332 (92.2)
Control38079 (20.8)301 (79.2)
χ2 value12.42212.422
P value0.0010.001
Table 2 Comparison of left ventricular function indices between the two groups
Group
n
LVEDD (mm)
LVEF (%)
Experimental36054.21 ± 5.3850.83 ± 8.38
Control38056.78 ± 4.9047.56 ± 5.47
t value6.3297.542
P value0.0340.027
Table 3 Comparison of adverse cardiovascular events between the two groups at 1 mo after operation, n (%)
Group
n
Malignant arrhythmia
Intractable myocardial ischemia
Congestive heart failure
Recurrent myocardial infarction
Death
Overall incidence
Experimental3603345116 (4.4)
Control38085714236 (9.5)
χ2 value9.124
P value0.001